Research Article
Potential Clinical Value of 5-Hydroxytryptamine Receptor 3C as a Prognostic Biomarker for Lung Cancer
Figure 4
Correlation analysis between HTR3C and oncogene expression in lung cancer patients. (a) Frequency of genomic alterations in tumors obtained from lung cancer patients. . (b) Table of major co-occurring genomic alterations in HTR3C-amplified NSCLC. (c) Analysis of the correlations between HTR3C and TP53/TTN/MUC16 mRNA expression levels using TIMER.
(a) |
(b) |
(c) |